Global Anti-Retroviral Drugs Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3494544
- 90 Pages
- February 2020
- Healthcare
The global Anti-Retroviral Drugs market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Anti-Retroviral Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Protease Inhibitors
Non-Nucleoside Reverse Transcriptase Inhibitors
Integrase Inhibitors
Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Cardionet
GE Healthcare
Abbott
AstraZeneca
Bristol-Myers-Squibb
Gilead
Cardiac Science Corp.
Cardiocom
Biotelemetry
GlaxoSmithKline
Roche
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hepatitis
HIV/AIDS
Herpes
Influenza
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Anti-Retroviral Drugs Industry
Figure Anti-Retroviral Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Anti-Retroviral Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Anti-Retroviral Drugs
1.2.2 Downstream
Table Application Segment of Anti-Retroviral Drugs
Table Global Anti-Retroviral Drugs Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Anti-Retroviral Drugs Market by Type
3.1 By Type
3.1.1 Protease Inhibitors
Table Major Company List of Protease Inhibitors
3.1.2 Non-Nucleoside Reverse Transcriptase Inhibitors
Table Major Company List of Non-Nucleoside Reverse Transcriptase Inhibitors
3.1.3 Integrase Inhibitors
Table Major Company List of Integrase Inhibitors
3.1.4 Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
Table Major Company List of Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
3.2 Market Size
Table Global Anti-Retroviral Drugs Market 2015-2019, by Type, in USD Million
Figure Global Anti-Retroviral Drugs Market Growth 2015-2019, by Type, in USD Million
Table Global Anti-Retroviral Drugs Market 2015-2019, by Type, in Volume
Figure Global Anti-Retroviral Drugs Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Anti-Retroviral Drugs Market Forecast 2020-2025, by Type, in USD Million
Table Global Anti-Retroviral Drugs Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Cardionet (Company Profile, Sales Data etc.)
4.1.1 Cardionet Profile
Table Cardionet Overview List
4.1.2 Cardionet Products & Services
4.1.3 Cardionet Business Operation Conditions
Table Business Operation of Cardionet (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 GE Healthcare (Company Profile, Sales Data etc.)
4.2.1 GE Healthcare Profile
Table GE Healthcare Overview List
4.2.2 GE Healthcare Products & Services
4.2.3 GE Healthcare Business Operation Conditions
Table Business Operation of GE Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Abbott (Company Profile, Sales Data etc.)
4.3.1 Abbott Profile
Table Abbott Overview List
4.3.2 Abbott Products & Services
4.3.3 Abbott Business Operation Conditions
Table Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 AstraZeneca (Company Profile, Sales Data etc.)
4.4.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.4.2 AstraZeneca Products & Services
4.4.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Bristol-Myers-Squibb (Company Profile, Sales Data etc.)
4.5.1 Bristol-Myers-Squibb Profile
Table Bristol-Myers-Squibb Overview List
4.5.2 Bristol-Myers-Squibb Products & Services
4.5.3 Bristol-Myers-Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers-Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Gilead (Company Profile, Sales Data etc.)
4.6.1 Gilead Profile
Table Gilead Overview List
4.6.2 Gilead Products & Services
4.6.3 Gilead Business Operation Conditions
Table Business Operation of Gilead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Cardiac Science Corp. (Company Profile, Sales Data etc.)
4.7.1 Cardiac Science Corp. Profile
Table Cardiac Science Corp. Overview List
4.7.2 Cardiac Science Corp. Products & Services
4.7.3 Cardiac Science Corp. Business Operation Conditions
Table Business Operation of Cardiac Science Corp. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Cardiocom (Company Profile, Sales Data etc.)
4.8.1 Cardiocom Profile
Table Cardiocom Overview List
4.8.2 Cardiocom Products & Services
4.8.3 Cardiocom Business Operation Conditions
Table Business Operation of Cardiocom (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Biotelemetry (Company Profile, Sales Data etc.)
4.9.1 Biotelemetry Profile
Table Biotelemetry Overview List
4.9.2 Biotelemetry Products & Services
4.9.3 Biotelemetry Business Operation Conditions
Table Business Operation of Biotelemetry (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 GlaxoSmithKline (Company Profile, Sales Data etc.)
4.10.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
4.10.2 GlaxoSmithKline Products & Services
4.10.3 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Roche (Company Profile, Sales Data etc.)
4.11.1 Roche Profile
Table Roche Overview List
4.11.2 Roche Products & Services
4.11.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Anti-Retroviral Drugs Sales Revenue 2015-2019, by Company, in USD Million
Table Global Anti-Retroviral Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Anti-Retroviral Drugs Sales Revenue Share in 2019, by Company, in USD Million
Table Global Anti-Retroviral Drugs Sales Volume 2015-2019, by Company, in Volume
Table Global Anti-Retroviral Drugs Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Anti-Retroviral Drugs Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Anti-Retroviral Drugs Market Concentration, in 2019
Figure Europe Anti-Retroviral Drugs Market Market Concentration, in 2019
Figure Asia-Pacific Anti-Retroviral Drugs MMarket Concentration, in 2019
Figure South America Anti-Retroviral Drugs Market Concentration, in 2019
Figure Middle East & Africa Anti-Retroviral Drugs Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hepatitis
Figure Anti-Retroviral Drugs Demand in Hepatitis, 2015-2019, in USD Million
Figure Anti-Retroviral Drugs Demand in Hepatitis, 2015-2019, in Volume
6.1.2 Demand in HIV/AIDS
Figure Anti-Retroviral Drugs Demand in HIV/AIDS, 2015-2019, in USD Million
Figure Anti-Retroviral Drugs Demand in HIV/AIDS, 2015-2019, in Volume
6.1.3 Demand in Herpes
Figure Anti-Retroviral Drugs Demand in Herpes, 2015-2019, in USD Million
Figure Anti-Retroviral Drugs Demand in Herpes, 2015-2019, in Volume
6.1.4 Demand in Influenza
Figure Anti-Retroviral Drugs Demand in Influenza, 2015-2019, in USD Million
Figure Anti-Retroviral Drugs Demand in Influenza, 2015-2019, in Volume
6.1.5 Demand in Others
Figure Anti-Retroviral Drugs Demand in Others, 2015-2019, in USD Million
Figure Anti-Retroviral Drugs Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Anti-Retroviral Drugs Demand Forecast 2020-2025, by Application, in USD Million
Figure Anti-Retroviral Drugs Market Growth 2020-2025, by Application, in USD Million
Figure Anti-Retroviral Drugs Market Share in 2025, by Application, in USD Million
Table Anti-Retroviral Drugs Demand Forecast 2020-2025, by Application, in Volume
Table Anti-Retroviral Drugs Market Growth 2020-2025, by Application, in Volume
Table Anti-Retroviral Drugs Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Anti-Retroviral Drugs Production 2015-2019, by Region, in USD Million
Table Anti-Retroviral Drugs Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Anti-Retroviral Drugs Market 2015-2019, by Region, in USD Million
Table Global Anti-Retroviral Drugs Market Share 2015-2019, by Region, in USD Million
Table Global Anti-Retroviral Drugs Market 2015-2019, by Region, in Volume
Table Global Anti-Retroviral Drugs Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Anti-Retroviral Drugs Market Size and Growth 2015-2019, in USD Million
Figure North America Anti-Retroviral Drugs Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Anti-Retroviral Drugs Market Size 2015-2019, by Country, in USD Million
Table North America Anti-Retroviral Drugs Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Anti-Retroviral Drugs Market Size and Growth 2015-2019, in USD Million
Figure Europe Anti-Retroviral Drugs Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Anti-Retroviral Drugs Market Size 2015-2019, by Country, in USD Million
Table Europe Anti-Retroviral Drugs Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Anti-Retroviral Drugs Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Anti-Retroviral Drugs Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Anti-Retroviral Drugs Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Anti-Retroviral Drugs Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Anti-Retroviral Drugs Market Size and Growth 2015-2019, in USD Million
Figure South America Anti-Retroviral Drugs Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Anti-Retroviral Drugs Market Size 2015-2019, by Country, in USD Million
Table South America Anti-Retroviral Drugs Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Anti-Retroviral Drugs Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Anti-Retroviral Drugs Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Anti-Retroviral Drugs Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Anti-Retroviral Drugs Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Anti-Retroviral Drugs Market Forecast 2020-2025, by Region, in USD Million
Table Anti-Retroviral Drugs Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
Table Upstream Segment of Anti-Retroviral Drugs
Table Application Segment of Anti-Retroviral Drugs
Table Global Anti-Retroviral Drugs Market 2015-2025, by Application, in USD Million
Table Major Company List of Non-Nucleoside Reverse Transcriptase Inhibitors
Table Major Company List of Integrase Inhibitors
Table Major Company List of Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
Table Global Anti-Retroviral Drugs Market 2015-2019, by Type, in USD Million
Table Global Anti-Retroviral Drugs Market 2015-2019, by Type, in Volume
Table Global Anti-Retroviral Drugs Market Forecast 2020-2025, by Type, in USD Million
Table Global Anti-Retroviral Drugs Market Forecast 2020-2025, by Type, in Volume
Table Cardionet Overview List
Table Business Operation of Cardionet (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GE Healthcare Overview List
Table Business Operation of GE Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Overview List
Table Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers-Squibb Overview List
Table Business Operation of Bristol-Myers-Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Overview List
Table Business Operation of Gilead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cardiac Science Corp. Overview List
Table Business Operation of Cardiac Science Corp. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cardiocom Overview List
Table Business Operation of Cardiocom (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biotelemetry Overview List
Table Business Operation of Biotelemetry (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Anti-Retroviral Drugs Sales Revenue 2015-2019, by Company, in USD Million
Table Global Anti-Retroviral Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Anti-Retroviral Drugs Sales Volume 2015-2019, by Company, in Volume
Table Global Anti-Retroviral Drugs Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Anti-Retroviral Drugs Demand Forecast 2020-2025, by Application, in USD Million
Table Anti-Retroviral Drugs Demand Forecast 2020-2025, by Application, in Volume
Table Anti-Retroviral Drugs Market Growth 2020-2025, by Application, in Volume
Table Anti-Retroviral Drugs Market Share in 2025, by Application, in Volume
Table Anti-Retroviral Drugs Production 2015-2019, by Region, in USD Million
Table Anti-Retroviral Drugs Production 2015-2019, by Region, in Volume
Table Global Anti-Retroviral Drugs Market 2015-2019, by Region, in USD Million
Table Global Anti-Retroviral Drugs Market Share 2015-2019, by Region, in USD Million
Table Global Anti-Retroviral Drugs Market 2015-2019, by Region, in Volume
Table Global Anti-Retroviral Drugs Market Share 2015-2019, by Region, in Volume
Table North America Anti-Retroviral Drugs Market Size 2015-2019, by Country, in USD Million
Table North America Anti-Retroviral Drugs Market Size 2015-2019, by Country, in Volume
Table Europe Anti-Retroviral Drugs Market Size 2015-2019, by Country, in USD Million
Table Europe Anti-Retroviral Drugs Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Anti-Retroviral Drugs Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Anti-Retroviral Drugs Market Size 2015-2019, by Country, in Volume
Table South America Anti-Retroviral Drugs Market Size 2015-2019, by Country, in USD Million
Table South America Anti-Retroviral Drugs Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Anti-Retroviral Drugs Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Anti-Retroviral Drugs Market Size 2015-2019, by Country, in Volume
Table Anti-Retroviral Drugs Market Forecast 2020-2025, by Region, in USD Million
Table Anti-Retroviral Drugs Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
